Exclusive: Fearing shortages, EU may deploy emergency funds in COVID-19 vaccine race
The European Commission is weighing using a $2.6 billion emergency fund to boost pharmaceutical labs’ capacity, fearing that even if a COVID-19 vaccine is developed the EU may not be able to produce enough shots, a document seen by Reuters shows.
